Delta4 in the Spotlight

Latest News & Events

A woman in a lab coat and glasses works on a laptop in a dimly lit room with multiple screens displaying data in the background, as part of the EU Horizon Research initiative. Other individuals also work at computers behind her, contributing to the collaborative effort.

Delta4: A Trusted Partner in EU Horizon Research Projects

August 22, 2024

Delta4 is proud to announce its participation in two significant EU Horizon research projects: PICKED (Personalized Medicine in Chronic Kidney ...

A scientist works on a computer displaying medical data. In the background, two other scientists conduct experiments in a lab. The environment is bright and clinical.

Delta4 Featured in the Finanz und Wirtschaft (FuW)

June 27, 2024

Delta4 is honored to have been featured in a recent article by Finanz und Wirtschaft, highlighting our pioneering work in ...

Five people gather around a desk, focusing on a computer screen. One person is seated and using the mouse, while the others stand behind observing. Indoor setting with natural light from large windows.

Biomedical Knowledge Graphs for Drug Discovery: Delta4’s Innovative Approach

June 14, 2024

The term “knowledge graph” describes the process of storing data in a graph-structured topology. A graph database consists of three ...

A doctor holding up a tablet with an image of a kidney.

Pioneering the Future of Nephrotic Syndrome Research with ARREST-NEPHROSIS

February 22, 2024

Nephrotic Syndrome affects millions globally, presenting a significant health burden with its hallmark symptoms of severe proteinuria and edema. The ...

Delta4 At BIO-Europe

November 30, 2023

Delta4 at BIO-Europe 2023: Fostering Partnerships and Driving Innovation We are excited to share Delta4’s presence at the recently concluded ...

Digital Health Envision Summit

October 31, 2023

We are delighted to announce that Dr. Klaus Kratochwill, CSO, and Dr. Paul Perco, Computational Biology Lead of Delta4, are ...

Diving deep into the realms of computational drug repurposing

Case Study: Unravelling the Multifaceted Potential of Iguratimod with Delta4’s Hyper-C Platform

October 19, 2023

Diving deep into the realms of computational drug repurposing, Delta4 leveraged its state-of-the-art Hyper-C platform with an ambitious objective: to ...

Delta4 at RExPO: Pushing the Boundaries of Drug Repurposing

October 4, 2023

We are thrilled to announce that Delta4 will be in attendance at this year’s RExPO23, a landmark event in the ...

Reactome Spotlights Delta4’s Computational Drug Repositioning of Clopidogrel for FSGS

October 1, 2023

We are honored to announce that our publication on the computational drug repositioning of clopidogrel has been highlighted in the ...

Delta4 joins the EU-funded COST action PerMediK (Personalized medicine in chronic kidney disease: improved outcome based on Big Data)

September 24, 2023

The scientific goal of PerMediK is to foster development toward personalized medicine in chronic kidney disease (CKD), based on multidimensional ...

Delta4’s Innovation Shines: OntoloViz Article Published in Bioinformatics Advances Journal

September 15, 2023

We are thrilled to announce that our journal article, titled “OntoloViz: a GUI for interactive visualization of ranked disease or ...

Delta4 Identifies a Potential New Therapeutic Option for Focal Segmental Glomerulosclerosis (FSGS) using computational Hyper-C Drug Discovery Platform

July 3, 2023

Delta4, a digital drug discovery company, identified a potential therapeutic option for Focal Segmental Glomerulosclerosis (FSGS) using their Hyper-C AI ...

Delta4 CEO Kurt Herpel Featured in Insightscare Magazine: A Vision for the Future of Drug Discovery

May 9, 2023

We are incredibly proud to share that our esteemed CEO, Kurt Herpel, has recently been profiled in Insightscare Magazine. In ...

Delta4 Announces Prof. Doron Lancet To Join Scientific Advisory Board

March 6, 2023

VIENNA, Austria, March 6th, 2023 — Delta4, a digital drug discovery company focusing on the identification of new indications for ...

Kurt Herpel, CEO of Delta4, and Revital Rattenbach, CEO of 4P-Pharma, celebrating the signature of a partnership agreement between Delta4 and 4P-Pharma in Paris (France).

4P-Pharma And Delta4 Join Forces To Find And Develop Treatments For A Rare Autoimmune Chronic Liver Disease

June 1, 2022

Paris (France) and Vienna (Austria), 31st May 2022 – 4P-Pharma, a French clinical-stage biotechnology company, and Delta4, an Austrian digital ...

Delta4, in preparation for the first clinical study, focused on FSGS

April 27, 2022

Focal Segmental Glomerulosclerosis (FSGS) is a devastating clinical condition with defined glomerular histopathology and yet a multifaceted pathophysiological, histological, and ...

Delta4 at BIO-EUROPE 2021

November 15, 2021

From October 25-28 Delta4 attended the (virtual) BIO-EUROPE conference, the largest partnering event in Europe dedicated to the global biotechnology ...

A hand holding a pen on a tablet in the dark.

Delta4 Announces Dr. Hans Lehrach to Join Scientific Advisory Board

September 27, 2021

VIENNA, Austria, September 27th, 2021 — Delta4, a digital drug discovery company focusing on the identification of new indications for ...

Two scientists in lab coats looking at a microscope.

Delta4 expands Team and tackles new indications

August 23, 2021

A Welcome to Our Newest Member Following our Financing in March 2021 and our move into new premises in July ...

Office News – July ’21

July 19, 2021

We are excited to announce that Delta4 has moved into a new office in the 8th district, close to the city ...

A calculator sits on top of a sheet of paper.

Alfred Steininger to Join Delta4 as CFO

June 25, 2021

We are very pleased to introduce Alfred Steininger as our new Chief Financial Officer, starting in mid-July 2021. Alfred brings ...

Press Release – April ’21

April 7, 2021

Delta4 Announces Closing of Multi-million Series A Financing Round Company to Expand Focus Beyond Renal Diseases and COVID-19 Compounds Identified ...

Photo by National Cancer Institute on unsplash.com

FSGS and COVID-19 programs ready for Phase II studies

February 15, 2021

We are proud to announce further progress in our current drug discovery and development programs. In late 2020, Delta4 filed ...

Delta4 files four patent applications in FSGS and COVID-19

December 4, 2020

We are very pleased to announce that Delta4 has filed four patent applications for compounds and combinations of compounds in ...

BIO-Europe 2020 Digital – Partnering Event

October 24, 2020

Global connections are more important than ever. With the same powerful one-to-one partnering and valuable content, BIO-Europe Digital continues to ...

Sachs 20th Annual Biotech In Europe Forum

September 29, 2020

The 20th Annual Biotech in Europe (BEF) Forum is recognized as the leading international Stage for those interested in investing ...

World Orphan Drug Congress

August 30, 2020

With over 1,500 attendees from 50+ countries, the 2020 edition of the World Orphan Drug Congress USA was held online ...

Press Release – June 2020

June 2, 2020

Delta4 Announces Results Achieved with Drug Discovery Platform Vienna, Europe (June 2, 2020) – Delta4, a biotech company using its ...

An image of a coronavirus on a white background.

COVID-19 – Call to Action

March 30, 2020

The global crisis caused by the SARS-Cov2 outbreak requires rapidly applicable therapeutics. Available approved drug substances represent one of the ...

A poster with the words discover cure january-february 2020 in san francisco.

Biotech Showcase 2020 @JPM San Francisco

January 13, 2020

What Is It? Biotech Showcase™ is an investor conference during JPM 2020, devoted to providing private and public biotech companies ...

LSX Investival

November 18, 2019

Delta4 Reflects on the 2020 LSX Investival Showcase: A Landmark Event in Life Sciences Innovation In November 2020, the prestigious ...

Life-Science Investment Days, Vienna

October 28, 2019

Delta4 Attends the Life Science Investment Days Event of 2019 The Life Science Investment Days event held in Vienna from ...

Biotech in Europe Forum (BEF)

September 27, 2019

Delta4’s Participation at the 19th Annual Biotech in Europe Forum: A Landmark Experience Delta4 was honored to attend the 19th ...